Corporate news

Duesseldorf, October 08, 2020—Gerresheimer AG has signed a promissory loan agreement for a total of EUR 325m. The transaction with an initial issue…

Implementation of growth strategy beginning to deliver results Group revenues increase to EUR 363m with 4.6% organic growth in core business 6.9%…

Duesseldorf, June 24, 2020—Payment of a dividend of EUR 1.20 per share was approved at the virtual Annual General Meeting of Gerresheimer AG. “In…

Stevanato Group, SCHOTT, and Gerresheimer confirm the readiness to support future Covid-19 Vaccine with pharmaceutical containers The CEOs of…

Duesseldorf, May 04, 2020—Gerresheimer AG will hold its planned Annual General Meeting on June 24, 2020 as a virtual annual general meeting. This has…

Stable business model as key supplier to pharma and healthcare industry Gerresheimer sustains growth path. Revenue guidance for 2020 in the mid…

Düsseldorf, March 24, 2020. We as Gerresheimer face up to the special situation in view of the corona virus which is spreading worldwide. We are…

Foundation for sustainable and profitable growth laid in 2019: Annual revenue growth in the mid-single-digit percentage range targeted for 2020 and…

SQ Innovation and Gerresheimer sign partnership for micro pumps for heart failure treatment Sanofi terminates development project for micro pumps…